Request Trial
shutterstock_1179311575_vchal
Vchal / Shutterstock.com
30 September 2019AmericasSarah Morgan

Taiwanese firm accuses Pacific Biosciences of infringing sequencing tech

In its suit, filed at the US District Court for the District of Delaware on Thursday, September 26, PGI accused Pacific Biosciences of infringing US patent 7,767,441 through the sale of its nucleic acid sequencing platform Sequel System.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
To cite or not to cite: How can we avoid misuse of AI in court?
4 March 2026   With an increase in ‘hallucinated’ case law cited as evidence in courts globally, what can legal practitioners—as well as providers of AI tools and platforms—do to help safeguard against this? Sarah Speight finds out.
Americas
LSPN Awards 2026 finalists revealed
2 March 2026   Law firms, companies and individuals have been shortlisted across a range of categories, which this year include new awards for excellence in PTAB, trade secrets and medical device work.
Americas
Natera and a rival draw the line under five-year fight
27 February 2026   The companies have agreed to dismiss their long-running patent fight over tumour-informed liquid biopsy technology, closing a high-stakes chapter in the fast-growing MRD testing market—while leaving the door open to future claims.


Editor's picks

LSPN Awards 2026 finalists revealed
Americas
LSPN Awards 2026 finalists revealed
2 March 2026

Editor's picks

Americas
LSPN Awards 2026 finalists revealed
2 March 2026
Americas
Eli Lilly escapes $278m payout in biotech licensing dispute
26 February 2026
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026
Asia
AstraZeneca partners with Chinese firm ahead of next obesity race
5 February 2026
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026

More features

DWT recruits first-chair trial litigator as latest hire in IP expansion
To cite or not to cite: How can we avoid misuse of AI in court?
Gowling WLG brings in transactions expert with UK and US experience
LSPN Awards 2026 finalists revealed
Natera and a rival draw the line under five-year fight
SCOTUS flooded with briefs calling for reversal of ‘skinny label’ ruling
Eli Lilly escapes $278m payout in biotech licensing dispute
Novo battles for GLP-1 leadership with fresh lawsuit and slashed prices